MEA Traceability

Step into the future of pharmaceutical compliance with confidence by embracing the Turkish Pharmaceutical Track and Trace System (iTS). Complying with the iTS is not just a regulatory necessity; it's a strategic imperative to ensure the safety, transparency, and integrity of your pharmaceutical operations in Turkey.

Egypt has established a comprehensive regulatory framework for pharmaceuticals through the Egyptian Pharmaceutical Track & Trace System (EPTTS), overseen by the Ministry of Health and Population. This pioneering initiative represents Egypt's commitment to safeguarding public health by ensuring the authenticity, safety, and traceability of medicinal products throughout the entire pharmaceutical supply chain.

In Ethiopia, the Ethiopian Food and Drug Authority (EFDA) plays a pivotal role in ensuring the safety, efficacy, and quality of pharmaceuticals. Central to its regulatory framework is the EFDA Traceability Directive, a comprehensive set of requirements designed to bolster the traceability of medicinal products within the pharmaceutical supply chain.

In Bahrain, the National Health Regulatory Authority (NHRA) establishes comprehensive regulations to safeguard pharmaceutical integrity throughout the supply chain. The NHRA's stringent regulatory framework represents Bahrain's dedication to ensuring medication authenticity, patient safety, and supply chain transparency through advanced traceability and verification systems.

In Zambia, the Zambia Medicines Regulatory Authority (ZAMRA) plays a pivotal role in safeguarding public health through comprehensive regulatory measures. ZAMRA's pharmaceutical traceability requirements serve as a cornerstone in the country's commitment to ensuring the authenticity and safety of medicinal products throughout the pharmaceutical supply chain. Based on the Medicines and Allied Substances Act No. 3 of 2013 and subsequent regulations, Zambia has established a robust framework to combat counterfeit medicines and enhance patient safety.

In Southern Africa, pharmaceutical regulations are progressively evolving toward enhanced traceability, safety, and quality assurance across the pharmaceutical supply chain. Countries in this region, many of which participate in the Southern African Development Community (SADC), are implementing increasingly sophisticated regulatory frameworks to combat counterfeit medications and ensure patient safety through improved supply chain integrity. The SADC region is made up of 15 Member States (Angola, Botswana, Democratic Republic of Congo, Lesotho, Mauritius, Madagascar, Malawi, Mozambique, Namibia, Seychelles, South Africa, Swaziland and United Republic of Tanzania (Mainland and Zanzibar). Source - https://tis.sadc.int/english/sarn/about-sarn/